Blood and Blood Components Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models

2.1. CXO Perspective

3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Whole Blood
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Blood Components
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Blood Derivatives
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country

5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Anemia
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Trauma Surgery
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Cancer Treatment
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Bleeding Disorders
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country

6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country

7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Blood and Blood Components Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Blood and Blood Components Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Blood and Blood Components Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Blood and Blood Components Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Blood and Blood Components Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Blood and Blood Components Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Blood and Blood Components Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Blood and Blood Components Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Russia Blood and Blood Components Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.3.12. Rest Of Europe Blood and Blood Components Market
7.3.12.1. Market Size and Forecast, By Product
7.3.12.2. Market Size and Forecast, By Application
7.3.12.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Blood and Blood Components Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Blood and Blood Components Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Blood and Blood Components Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Blood and Blood Components Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Blood and Blood Components Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Thailand Blood and Blood Components Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.4.12. Malaysia Blood and Blood Components Market
7.4.12.1. Market Size and Forecast, By Product
7.4.12.2. Market Size and Forecast, By Application
7.4.12.3. Market Size and Forecast, By End User
7.4.13. Indonesia Blood and Blood Components Market
7.4.13.1. Market Size and Forecast, By Product
7.4.13.2. Market Size and Forecast, By Application
7.4.13.3. Market Size and Forecast, By End User
7.4.14. Rest of Asia-Pacific Blood and Blood Components Market
7.4.14.1. Market Size and Forecast, By Product
7.4.14.2. Market Size and Forecast, By Application
7.4.14.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Blood and Blood Components Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Blood and Blood Components Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Blood and Blood Components Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. UAE Blood and Blood Components Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
7.5.10. Argentina Blood and Blood Components Market
7.5.10.1. Market Size and Forecast, By Product
7.5.10.2. Market Size and Forecast, By Application
7.5.10.3. Market Size and Forecast, By End User
7.5.11. Rest of LAMEA Blood and Blood Components Market
7.5.11.1. Market Size and Forecast, By Product
7.5.11.2. Market Size and Forecast, By Application
7.5.11.3. Market Size and Forecast, By End User

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

9.1. Becton
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Dickinson And Co.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Kidde-Fenwal Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Cerus Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Immucor
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Beckman Coulter, Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. BioMerieux SA
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Octapharma AG
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Abbott
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments

Table 1. Global Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 2. Blood and Blood Components Market for Whole Blood, by Region, 2024 - 2033 ($Billion)
Table 3. Blood and Blood Components Market for Blood Components, by Region, 2024 - 2033 ($Billion)
Table 4. Blood and Blood Components Market for Blood Derivatives, by Region, 2024 - 2033 ($Billion)
Table 5. Global Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 6. Blood and Blood Components Market for Anemia, by Region, 2024 - 2033 ($Billion)
Table 7. Blood and Blood Components Market for Trauma Surgery, by Region, 2024 - 2033 ($Billion)
Table 8. Blood and Blood Components Market for Cancer Treatment, by Region, 2024 - 2033 ($Billion)
Table 9. Blood and Blood Components Market for Bleeding Disorders, by Region, 2024 - 2033 ($Billion)
Table 10. Global Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 11. Blood and Blood Components Market for Hospitals, by Region, 2024 - 2033 ($Billion)
Table 12. Blood and Blood Components Market for Ambulatory Surgical Centers, by Region, 2024 - 2033 ($Billion)
Table 13. Blood and Blood Components Market for Others, by Region, 2024 - 2033 ($Billion)
Table 14. Blood and Blood Components Market, by Region, 2024 - 2033 ($Billion)
Table 15. North America Blood and Blood Components Market, by Country, 2024 - 2033 ($Billion)
Table 16. North America Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 17. North America Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 18. North America Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 19. U.S. Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 20. U.S. Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 21. U.S. Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 22. Canada Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 23. Canada Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 24. Canada Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Mexico Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 26. Mexico Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 27. Mexico Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 28. Europe Blood and Blood Components Market, by Country, 2024 - 2033 ($Billion)
Table 29. Europe Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 30. Europe Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 31. Europe Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 32. France Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 33. France Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 34. France Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 35. Germany Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 36. Germany Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 37. Germany Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 38. Italy Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 39. Italy Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 40. Italy Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 41. Spain Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 42. Spain Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 43. Spain Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 44. UK Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 45. UK Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 46. UK Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 47. Russia Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 48. Russia Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 49. Russia Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 50. Rest of Europe Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 51. Rest of Europe Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 52. Rest of Europe Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 53. Asia-Pacific Blood and Blood Components Market, by Country, 2024 - 2033 ($Billion)
Table 54. Asia-Pacific Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 55. Asia-Pacific Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 56. Asia-Pacific Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 57. China Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 58. China Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 59. China Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 60. Japan Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 61. Japan Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 62. Japan Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 63. India Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 64. India Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 65. India Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 66. South Korea Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 67. South Korea Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 68. South Korea Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 69. Australia Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 70. Australia Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 71. Australia Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 72. Thailand Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 73. Thailand Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 74. Thailand Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 75. Malaysia Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 76. Malaysia Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 77. Malaysia Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 78. Indonesia Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 79. Indonesia Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 80. Indonesia Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 81. Rest of Asia-Pacific Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 82. Rest of Asia-Pacific Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 83. Rest of Asia-Pacific Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 84. LAMEA Blood and Blood Components Market, by Country, 2024 - 2033 ($Billion)
Table 85. LAMEA Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 86. LAMEA Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 87. LAMEA Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 88. Brazil Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 89. Brazil Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 90. Brazil Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 91. South Africa Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 92. South Africa Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 93. South Africa Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 94. Saudi Arabia Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 95. Saudi Arabia Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 96. Saudi Arabia Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 97. UAE Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 98. UAE Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 99. UAE Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 100. Argentina Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 101. Argentina Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 102. Argentina Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 103. Rest of LAMEA Blood and Blood Components Market, by Product, 2024 - 2033 ($Billion)
Table 104. Rest of LAMEA Blood and Blood Components Market, by Application, 2024 - 2033 ($Billion)
Table 105. Rest of LAMEA Blood and Blood Components Market, by End-user, 2024 - 2033 ($Billion)
Table 106. Becton: Key Executives
Table 107. Becton: Company Snapshot
Table 108. Becton: Operating Segments
Table 109. Becton: Product Portfolio
Table 110. Becton: Key Strategic Moves and Developments
Table 111. Dickinson and Co.: Key Executives
Table 112. Dickinson and Co.: Company Snapshot
Table 113. Dickinson and Co.: Operating Segments
Table 114. Dickinson and Co.: Product Portfolio
Table 115. Dickinson and Co.: Key Strategic Moves and Developments
Table 116. Kidde-Fenwal Inc.: Key Executives
Table 117. Kidde-Fenwal Inc.: Company Snapshot
Table 118. Kidde-Fenwal Inc.: Operating Segments
Table 119. Kidde-Fenwal Inc.: Product Portfolio
Table 120. Kidde-Fenwal Inc.: Key Strategic Moves and Developments
Table 121. Bio-Rad Laboratories, Inc.: Key Executives
Table 122. Bio-Rad Laboratories, Inc.: Company Snapshot
Table 123. Bio-Rad Laboratories, Inc.: Operating Segments
Table 124. Bio-Rad Laboratories, Inc.: Product Portfolio
Table 125. Bio-Rad Laboratories, Inc.: Key Strategic Moves and Developments
Table 126. Cerus Corporation: Key Executives
Table 127. Cerus Corporation: Company Snapshot
Table 128. Cerus Corporation: Operating Segments
Table 129. Cerus Corporation: Product Portfolio
Table 130. Cerus Corporation: Key Strategic Moves and Developments
Table 131. Immucor: Key Executives
Table 132. Immucor: Company Snapshot
Table 133. Immucor: Operating Segments
Table 134. Immucor: Product Portfolio
Table 135. Immucor: Key Strategic Moves and Developments
Table 136. Beckman Coulter, Inc.: Key Executives
Table 137. Beckman Coulter, Inc.: Company Snapshot
Table 138. Beckman Coulter, Inc.: Operating Segments
Table 139. Beckman Coulter, Inc.: Product Portfolio
Table 140. Beckman Coulter, Inc.: Key Strategic Moves and Developments
Table 141. Biomerieux SA: Key Executives
Table 142. Biomerieux SA: Company Snapshot
Table 143. Biomerieux SA: Operating Segments
Table 144. Biomerieux SA: Product Portfolio
Table 145. Biomerieux SA: Key Strategic Moves and Developments
Table 146. Octapharma AG: Key Executives
Table 147. Octapharma AG: Company Snapshot
Table 148. Octapharma AG: Operating Segments
Table 149. Octapharma AG: Product Portfolio
Table 150. Octapharma AG: Key Strategic Moves and Developments
Table 151. Abbott: Key Executives
Table 152. Abbott: Company Snapshot
Table 153. Abbott: Operating Segments
Table 154. Abbott: Product Portfolio
Table 155. Abbott: Key Strategic Moves and Developments

Figure 1. Global Blood and Blood Components Market, 2024 - 2033
Figure 2. Segmentation of Blood and Blood Components Market, 2024 - 2033
Figure 3. Top Investment Pocket in Blood and Blood Components Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalblood and Blood Components Market
Figure 10. Global Blood and Blood Components Market Segmentation, by Product
Figure 11. Blood and Blood Components Market for Whole Blood, by Country, 2024 - 2033 ($Billion)
Figure 12. Blood and Blood Components Market for Blood Components, by Country, 2024 - 2033 ($Billion)
Figure 13. Blood and Blood Components Market for Blood Derivatives, by Country, 2024 - 2033 ($Billion)
Figure 14. Global Blood and Blood Components Market Segmentation, by Application
Figure 15. Blood and Blood Components Market for Anemia, by Country, 2024 - 2033 ($Billion)
Figure 16. Blood and Blood Components Market for Trauma Surgery, by Country, 2024 - 2033 ($Billion)
Figure 17. Blood and Blood Components Market for Cancer Treatment, by Country, 2024 - 2033 ($Billion)
Figure 18. Blood and Blood Components Market for Bleeding Disorders, by Country, 2024 - 2033 ($Billion)
Figure 19. Global Blood and Blood Components Market Segmentation, by End-user
Figure 20. Blood and Blood Components Market for Hospitals, by Country, 2024 - 2033 ($Billion)
Figure 21. Blood and Blood Components Market for Ambulatory Surgical Centers, by Country, 2024 - 2033 ($Billion)
Figure 22. Blood and Blood Components Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 23. Top Winning Strategies, by Year, 2021-2023*
Figure 24. Top Winning Strategies, by Development, 2021-2023*
Figure 25. Top Winning Strategies, by Company, 2021-2023*
Figure 26. Product Mapping of Top 10 Players
Figure 27. Competitive Dashboard
Figure 28. Competitive Heatmap: Blood and Blood Components Market
Figure 29. Top Player Positioning, 2023
Figure 30. Becton: Net Sales, 2021-2023 ($Billion)
Figure 31. Becton: Revenue Share, by Segment, 2023 (%)
Figure 32. Becton: Revenue Share, by Region, 2023 (%)
Figure 33. Dickinson and Co.: Net Sales, 2021-2023 ($Billion)
Figure 34. Dickinson and Co.: Revenue Share, by Segment, 2023 (%)
Figure 35. Dickinson and Co.: Revenue Share, by Region, 2023 (%)
Figure 36. Kidde-Fenwal Inc.: Net Sales, 2021-2023 ($Billion)
Figure 37. Kidde-Fenwal Inc.: Revenue Share, by Segment, 2023 (%)
Figure 38. Kidde-Fenwal Inc.: Revenue Share, by Region, 2023 (%)
Figure 39. Bio-Rad Laboratories, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 40. Bio-Rad Laboratories, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 41. Bio-Rad Laboratories, Inc.: Revenue Share, by Region, 2023 (%)
Figure 42. Cerus Corporation: Net Sales, 2021-2023 ($Billion)
Figure 43. Cerus Corporation: Revenue Share, by Segment, 2023 (%)
Figure 44. Cerus Corporation: Revenue Share, by Region, 2023 (%)
Figure 45. Immucor: Net Sales, 2021-2023 ($Billion)
Figure 46. Immucor: Revenue Share, by Segment, 2023 (%)
Figure 47. Immucor: Revenue Share, by Region, 2023 (%)
Figure 48. Beckman Coulter, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 49. Beckman Coulter, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 50. Beckman Coulter, Inc.: Revenue Share, by Region, 2023 (%)
Figure 51. Biomerieux SA: Net Sales, 2021-2023 ($Billion)
Figure 52. Biomerieux SA: Revenue Share, by Segment, 2023 (%)
Figure 53. Biomerieux SA: Revenue Share, by Region, 2023 (%)
Figure 54. Octapharma AG: Net Sales, 2021-2023 ($Billion)
Figure 55. Octapharma AG: Revenue Share, by Segment, 2023 (%)
Figure 56. Octapharma AG: Revenue Share, by Region, 2023 (%)
Figure 57. Abbott: Net Sales, 2021-2023 ($Billion)
Figure 58. Abbott: Revenue Share, by Segment, 2023 (%)
Figure 59. Abbott: Revenue Share, by Region, 2023 (%)